MedPath

Study comparing the efficacy of intravenous oxytocin and intravenous carbetocin in haemodynamic stability of patients undergoing caesarean section under spinal anesthesia

Phase 3
Conditions
Health Condition 1: 1- Obstetrics
Registration Number
CTRI/2022/08/044710
Lead Sponsor
Sabari C G S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Age between 18 to 40 years.

2)American Society of Anaesthesiologists physical status II

3)Patients undergoing elective caesarean section under regional anaesthesia.

4)Provides Consent.

Exclusion Criteria

1)Presence of hypertension, preeclampsia, cardiac, renal or liver diseases, epilepsy and patients undergoing general anaesthesia.

2)Patient who are unable or unwilling to give consent.

�Women with history of hypersensitivity to carbetocin.

�Patients who do not fulfil inclusion criteria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to compare the haemodynamic effects of oxytocin and carbetocinTimepoint: 15 seconds before giving drug <br/ ><br>every 15 seconds for 5 minutes after giving drug
Secondary Outcome Measures
NameTimeMethod
use of additional uterotonic agents <br/ ><br>haemoglobin level preoperatively andTimepoint: 2 hours and 24 hours postoperatively
© Copyright 2025. All Rights Reserved by MedPath